Overview
Each year, the Conference Forum holds the R&D Leadership Summit®, a private event for primarily senior-level R&D executives and CEOs from mid to large pharma and biotech companies, to address timely and relevant issues impacting R&D decision-making. The 2024 dates were March 4-5 at the Eau Palm Beach in Manalapan, Florida. The 2024 theme was focused on accelerating R&D productivity enhancement opportunities.
Huge thanks to lead advisors Fred Hassan, Managing Director, Healthcare, Warburg Pincus, Thomas Koestler, PhD, Executive Director, Vatera Health Care Partners, Mathai Mammen, MD, PhD, CEO, FogPharma, Alise Reicin, MD, CEO, Tectonic Therapeutics, Mark Simon, Advisor, Stifel and Sun Pharma, David Reese, MD, EVP and Chief Technology Officer, Amgen, Andy Plump, MD, PhD, President, R&D, Takeda and Ron Cohen, MD, President and CEO, Acorda Therapeutics for their guidance and support on the program agenda.
Dr John Reed and Fred Hassan
Dr Anna Barker and Dr Laura Esserman
Dr Meeta Chatterjee and Dr David Reese
We are grateful for the support and participation
from advisors and attendees
Houman Ashrafian BM, BCh, PhD
Executive Vice President, Global Head of R&D Sanofi
Ann D Barker, PhD, FAACR
Chief Strategy Officer, The Ellison Institute
Roy Baynes, MD, PhD
EVP and Chief Medical Officer, Eikon Therapeutics, Inc
Jeffrey Berkowitz
CEO and Director, Real Endpoints
Azad Bonni, MD, PhD
SVP, Global Head of Neuroscience and Rare Diseases, Roche Pharma Research & Early Development
Amitabh Chandra, PhD
Professor of Business Administration and Public Policy, Harvard University
Meeta Chatterjee, PhD
Chief Strategy Officer, Sun Pharmaceutical Industries, Inc
Ron Cohen, MD, PhD
President and CEO, Acorda Therapeutics
Rena Conti, PhD
Associate Professor, Markets, Public Policy and Law, Boston University Questrom School of Business
John F. Crowley, MBA, CEO,
BIO and Executive Chairman, Amicus Therapeutics
Steve Cutler, PhD
CEO, ICON
Mikael Dolsten, MD, PhD
Chief Scientific Officer and President, Worldwide Research, Development and Medical, Pfizer Inc.
Steve Frank
Chairman of Global Healthcare Investment Banking, JP Morgan
Ronny Gal, PhD
Chief Strategy and Growth Officer, Novartis
Levi Garraway, MD, PhD
EVP, Head of Global Product Development and CMO, Genentech
Keith Gottesdiener, MD
President & CEO, Prime Medicine
Steve Harr, MD
President and CEO, Sana Biotechnology
Fred Hassan
Managing Director, Healthcare, Warburg Pincus
Rachel Haurwitz, PhD
President & CEO, Caribou Biosciences
Colin Hill
CEO & Co-Founder, Aitia Bio
Paul Hudson
CEO, Sanofi
Eric Hughes, MD, PhD
EVP, Global R&D and Chief Medical Officer, Teva
Melanie Ivarsson, OBE, PhD, MBA
Chief Development Officer, Moderna
Najat Khan, PhD
Chief Data Science Officer and Global Head Strategy & Operations, R&D, The Janssen Pharmaceutical Companies of Johnson & Johnson
Andy Lee
SVP, Head of Global Clinical Trial Operations, Merck
Roger Longman
Founder & Chairman, Real Endpoints
Mathai Mammen, MD, PhD
CEO, FogPharma
Chronis Manolis, RPh
SVP, Pharmacy Services, Chief Pharmacy Officer, UPMC Insurance Services Division
Clive Meanwell, MD
Chairman and Partner, Population Health Partners
Bill Mezzanotte, MD, MPH
EVP, Head of R&D and Chief Executive Officer, CSL
Mark McKenna, MBA,
CEO, Mirador Therapeutics
Philip Needleman, MD, PhD
Professor and Chairman of Department of Pharmacology, Washington University School of Medicine, St Louis
Frank O. Nestle, MD, FMedSci
Global Head of Research and CSO, Sanofi
Karen Peterson
Patient Advocate
Andy Plump, MD, PhD
President, R&D, Takeda
Sylke Poehling, PhD
SVP and Global Head, Therapeutic Modalities, Pharma Research & Early Development, Roche
Sumant Ramachandra, MD, PhD
CEO & President, ImmPACT Bio
John Reed, MD, PhD
EVP, Innovative Medicine, R&D, Johnson & Johnson
David Reese, MD
EVP and Chief Technology Officer, Amgen
Alise Reicin, MD
CEO & President, Tectonic Therapeutics
Brent Saunders, MBA
Chairman and CEO, Bausch + Lomb
Michael Sherman, MD, MBA
Venture Partner, RA Ventures RA Capital Management
Mark Simon, MBA
Advisor, Stifel and Sun Pharmaceutical Industries, Inc
Alexandra Snyder, MD
Head of R&D and CMO, Generate Biomedicines
Badhri Srinivasan
Head, Global Development Operations, Novartis
Mary Szela
CEO and President, TriSalus Life Sciences
Lambert van der Walde
SVP, Executive Director, Center for Health Care Research, UnitedHealth Group
Christopher Viehbacher
President and CEO, Biogen
Anne Wojcicki
Co-Founder and CEO, 23&Me
George Yancopoulos, MD, PhD
Co-Founder, President & CSO, Regeneron
Tal Zaks, MD, PhD
Venture Partner, OrbiMed
Elias Zerhouni, MD
Emeritus Professor, Johns Hopkins University
We are grateful for the support
and participation from our past keynotes
Robert Bradway
CEO, Amgen
Robert M. Davis
Chairman and CEO, Merck
Joaquin Duato
CEO and Chairman of the Board, Johnson & Johnson
Deborah Dunsire, MD
Former CEO, Lundbeck
Kenneth Frazier
Chairman of the Board and CEO, Merck & Co
Scott Gottlieb, MD
23rd Commissioner, U.S. Food and Drug Administration
CNBC Contributor
Bahija Jallal, PhD
former CEO, MedImmune
Daphne Koller, PhD
Founder & CEO, insitro
Vas Narasimhan, MD
CEO, Novartis
Lars Rebien Sorensen
former CEO, Novo Nordisk
Brent Saunders
CEO and chairman, Bausch + Lomb
Rupert Vessey, DPhil
Chief Scientist, Executive Partner, Flagship Pioneering
Christopher Viehbacher
President and CEO, Biogen
George Yancopoulos, MD, PhD
Co-Founder, President & CSO, Regeneron
Many thanks to the executive team at ICON for all their support and to the entire speaking faculty, who brought their vast experience together to identify and collaborate over ideas that will advance therapeutics for the benefit of patients.
Our guests are as much a part of the event as our speaking faculty. Our ultimate goal is to foster a Summit environment that inspires positive change to advance R&D and to provide support for the leaders behind the movement.
For questions about the R&D Leadership Summit, please contact Tracey Kimball at Tracey@tcfllc.org or Valerie Bowling at Valerie@tcfllc.org.
